BioSpace News Archive

Genetown

BlueRock Therapeutics to Participate at Upcoming Conferences

BlueRock Therapeutics, LP, an engineered cell therapy company leveraging its novel Cell+Gene platform to develop regenerative medicines for intractable diseases, today announced that the company will present at the following upcoming conferences

November 7, 2018
·
1 min read
Business

Impel NeuroPharma Appoints Ellen A. Lubman As Chief Business Officer

Impel NeuroPharma, a Seattle-based, privately-held biotechnology company focused on developing therapies for the treatment of central nervous system (CNS) disorders with unmet medical needs, today announced the appointment of Ellen A. Lubman as Chief Business Officer.

November 7, 2018
·
3 min read
Business

Clovis Oncology to Present at the Credit Suisse 27th Annual Healthcare Conference

Clovis Oncology (Nasdaq: CLVS) today announced that Patrick J. Mahaffy, Chief Executive Officer and President, will present at the 27th Annual Healthcare Conference on Wednesday, November 14, 2018 at 11:30 AM Mountain Time.

November 7, 2018
·
1 min read
BioMidwest

In Recognition of National Diabetes Awareness Month and Veteran’s Day, Roche Honors the One in Four Veterans Living With Diabetes at iHeartCountry One Night For Our Military Concert

Raising Awareness for the More Than 30 Million Americans with Diabetes

November 7, 2018
·
9 min read
Grupo Natac S.L. and Radient Technologies Launch Natac Solutions at SupplySide West

Advanced-Efficacy Extracts Offer Condition-Specific Functional Benefits

November 7, 2018
·
5 min read
Business

Alnylam Pharmaceuticals Reports Third Quarter 2018 Financial Results and Highlights Recent Period Activity

Obtained FDA and EMA Approvals of ONPATTRO™ (patisiran) – the First-Ever RNAi Therapeutic – and Launched in U.S. and EU

November 7, 2018
·
25 min read
Job Trends

Ampio Updates Regulatory and Clinical Status for Ampion™

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today is providing an update of the regulatory and clinical path activities required to file a Biologics License Application (BLA) for Ampion™ for the treatment of severe osteoarthritis-of-the-knee (OAK).

November 7, 2018
·
6 min read
Theravance Biopharma to Present at the Credit Suisse 27th Annual Healthcare Conference

Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that management will present a corporate overview at the Credit Suisse 27th Annual Healthcare Conference on Wednesday, November 14, 2018, at 8:35 a.m. MST.

November 7, 2018
·
2 min read
Job Trends

Evolve Formulas Transdermal NanoSerum™ CBD Met with Unprecedented Response across Colorado Market

Industry-First Formulation Harnesses the Anti-Inflammatory Qualities of CBD and Antioxidant Power of Resveratrol for Maximum Wellness Benefits

November 7, 2018
·
6 min read
Business

Applied DNA Subsidiary LineaRx Provides Cost and Quality Advantages to Technogenetics Diagnostic Solutions

Large-Scale Production of Linear DNA Shows the Best Lot-To-Lot Reproducibility and Sequence Accuracy for Kits Targeting Autoimmunity and Infectious Diseases

November 7, 2018
·
6 min read